Drug Discovery

UC Davis Health studies show that obesity induces immune suppression and promotes tumor growth through mechanisms that can be reversed using checkpoint inhibitor immunotherapy. The paradoxical findings give cancer doctors important new information when choosing drugs and other treatments for cancer patients.

Checkpoint blockade may be key for immunity to malaria

Genocea will carry out a joint research project with Dana-Farber and Harvard Medical School to characterize antitumor T-cell responses in melanoma patients.

Firm completed tech transfer process from UPenn to Progenitor Cell Therapy’s California site.

In addition to Zhejiang Tianyuan BioPharmaceuticals, Novartis invests in a new Institute for BioMedical Research in Shanghai and a center for APIs in Changshu.

Firm is building the TrueMAB collection to cover the entire human genome and will consist of antibodies that are significantly different from many on the market.

Combined company's lead compound will be Madrigal’s Phase II-ready MGL-3196, indicated for HeFH and HoFH as well as NASH

Teva will use the panel in its R&D activities, and Compugen plans to commercialize it later this year. Teva Pharmaceutical Industries exercised its option to...

Scientists from Denmark and Switzerland say they have shown that bacteria produce a stress molecule, divide more slowly, and thus save energy when they...

Institute expects improved standards to reduce costs and need to outsource production work.